Concepedia

The effects of the FDA warning on the use of droperidol by u.s. Emergency physicians.

John R. Richards, Steven J. Weiss, Stephen W. Bretz, Aaron Schneir, Dauna Rinetti, Robert W. Derlet

PubMed · 2003 · 16 citations · 5 references

Abstract

Based on this survey, EP use of droperidol has decreased dramatically as a result of the FDA warning. However, EPs believe that there are few or no alternative antiemetic drugs that have an improved adverse effect profile.

References

5

Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo

Robert P. Hill, David A. Lubarsky, Jennifer T. Fortney et al. · Anesthesiology · 2000 · 361 citations · Full text

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

Harold A. Thomas, Earl Schwartz, Robert Petrilli · Annals of Emergency Medicine · 1992 · 177 citations

, , +10

Droperidol vs. Prochlorperazine for Benign Headaches in the Emergency Department

James R. Miner, Sara J. Fish, Stephen W. Smith et al. · Academic Emergency Medicine · 2001 · 93 citations · Full text

Droperidol

R. Andrew Chambers, Benjamin G. Druss · The Journal of Clinical Psychiatry · 1999 · 35 citations

Variation in practice patterns of anesthesiologists in California for prophylaxis of postoperative nausea and vomiting

Alex Macario, Anthony Chung, Matthew B. Weinger · Journal of Clinical Anesthesia · 2001 · 28 citations

, , +10